Literature DB >> 20827072

Invasive candidiasis in critically ill patients: does progressing knowledge improve clinical management and outcome?

Oscar Marchetti1, Philippe Eggimann, Thierry Calandra.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20827072     DOI： 10.1097/MCC.0b013e32833e2629

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN： 1070-5295            Impact factor:   3.687


× No keyword cloud information.
  5 in total

1.  Fungal "colonisation" is associated with increased mortality in medical intensive care unit patients with liver cirrhosis.

Authors:  Tobias Lahmer; Marlena Messer; Ulrich Mayr; Bernd Saugel; Sebastian Noe; Caroline Schultheiss; Philipp Thies; Christoph Spinner; Simon Nennstiel; Christiane Schwerdtfeger; Veit Phillip; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2014-10-28       Impact factor: 2.574

2.  Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis.

Authors:  Antonietta Vella; Elena De Carolis; Luisa Vaccaro; Patrizia Posteraro; David S Perlin; Markus Kostrzewa; Brunella Posteraro; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

3.  An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis.

Authors:  Winnie Lee; Yixin Liew; Maciej Piotr Chlebicki; Sharon Ong; Pang Lee; Andrea Kwa
Journal:  Crit Care Res Pract       Date:  2014-05-15

4.  Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.

Authors:  Patrick J van der Geest; Nicole G M Hunfeld; Sophie E Ladage; A B Johan Groeneveld
Journal:  BMC Infect Dis       Date:  2016-09-15       Impact factor: 3.090

Review 5.  Disseminated Candidiasis in a Young, Previously Healthy, Dog and Review of Literature.

Authors:  Nicole Willems; Dirk J Houwers; Yvette M Schlotter; Bart Theelen; Teun Boekhout
Journal:  Mycopathologia       Date:  2016-11-30       Impact factor: 2.574
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.